Prevero was selected from a short-list of vendors for its future-oriented development approach and the ability to integrate a separate module for HR management. Another decisive aspect was its ability to meet the requirements of both Dr. Rentschler Holding and its subsidiaries.
Dr. Rentschler Holding started its selection process with extensive market research and chose prevero based on its impressive proof of concept. Originally intended solely for Dr. Rentschler Holding, implementation of the solution has now expanded to include Rentschler Biopharma.
Robert Schmid, project leader at Rentschler Holding said: "We realised very quickly that the solution could deliver a broad variety of requirements, and that we could achieve more with it than originally planned.
"Our goal was to optimise the quality and reliability of data across all subsidiaries. When the project is complete, we will have more time to analyse business information instead of just generating it."
Thomas Lottner, Vice President Finance at Rentschler Biopharma, said: "prevero's solution enables us to monitor all the development and production steps of our complex service business.
"With a rolling 48-month forecast against specific KPIs, we are better able to manage in a future-oriented way. Moreover, the system helps us establish a single point of truth. The development and production divisions can focus on core activities and continue to ensure superior quality for our clients."
Matthias Thurner, CTO and co-founder of prevero, added: "We are very happy that our solution and approach convinced Rentschler to select us. We will do everything we can to provide our new customer with optimal support and assist them through every step of the rollout."
Rentschler Holding is planning to launch the solution including all functions for reporting, planning, analysis and simulation in February 2018.
About Dr. Rentschler Holding GmbH & Co. KGDr. Rentschler Holding GmbH & Co. KG, headquartered in Laupheim, Germany, is a family-owned company with companies in the fields of biotechnology, investment and real estate.
About Rentschler Biopharma SERentschler Biopharma GmbH, located in Laupheim, Germany, is a leading contract development and manufacturing organization (CDMO) for bioprocess development and biomanufacturing as well as regulatory support. The Company's clients include innovative biotech companies as well as major pharmaceutical companies around the world, especially in Europe, North America and Asia. Many years of experience, excellence in finding solutions as well as certified quality management and advanced technologies ensure Rentschler's high quality standard. Rentschler is a privately held company employing 770 people.
About prevero Groupprevero, a Unit4 company, provides Corporate Performance Management (CPM) and Business Intelligence (BI) solutions for planning, budget ing, forecasting, data analysis, dashboarding and reporting, supporting companies of all sizes in making smart decisions across every part of the business. Additional prevero functionality covers financial and operational planning, project planning, HR planning, strategy planning, risk planning and financial consolidation, and the company also supports the specific needs of industries such as energy, manufacturing, finance, airports, telecommunications and the automotive sector.
Headquartered in Munich with additional offices in Europe, Asia and the USA, prevero employs 160 people and maintains an international partner network. The company helps more than 4,500 international clients including Bond Dickinson, GoCompare, Hotels & More, Bizerba, Konica Minolta, Swiss Life and Swisscom.